MARKET

PVCT

PVCT

Provectus Biopha
OTCMQB
0.193
-0.001
-0.67%
Closed 15:54 05/17 EDT
OPEN
0.186
PREV CLOSE
0.194
HIGH
0.193
LOW
0.186
VOLUME
125.70K
TURNOVER
23.55K
52 WEEK HIGH
0.221
52 WEEK LOW
0.034
MARKET CAP
80.93M
P/E (TTM)
-26.0676
1D
5D
1M
3M
1Y
5Y
PVCT Stock Earnings: Provectus Reported Results for Q1 2024
Provectus (OTCMKTS:PVCT) just reported results for the first quarter of 2024. The company did not report any EPS for the quarter. ProvectUS reported revenue of $238,072. The company reported no earnings per share.
Investorplace · 4d ago
Financial Report Articles: Comprehensive Analysis of Stock, Capital, and Earnings
Press release · 4d ago
PROVECTUS BIOPHARMACEUTICALS ANNOUNCES EIGHT PRESENTATIONS OF ROSE BENGAL PHOTODYNAMIC ANTIMICROBIAL THERAPY AT ARVO 2024 ANNUAL MEETING
Reuters · 5d ago
Weekly Report: what happened at PVCT last week (0506-0510)?
Weekly Report · 6d ago
Weekly Report: what happened at PVCT last week (0429-0503)?
Weekly Report · 05/06 10:19
Weekly Report: what happened at PVCT last week (0422-0426)?
Weekly Report · 04/29 10:23
Weekly Report: what happened at PVCT last week (0415-0419)?
Weekly Report · 04/22 10:17
Provectus Pharmaceuticals Announces New Leadership and Strategy
TipRanks · 04/16 21:12
More
About PVCT
Provectus Biopharmaceuticals, Inc. is a development-stage biopharmaceutical company. The Company is engaged in developing pharmaceuticals for oncology and dermatology indications. The Company is focused on developing its prescription drug candidates, PV-10 and PH-10. It is developing PV-10 for treatment of several life threatening cancers, including metastatic melanoma, liver cancer and breast cancer. It is developing PH-10 to provide minimally invasive treatment of chronic severe skin afflictions, such as psoriasis and atopic dermatitis, a type of eczema. In addition to clinical trials, patients enrolled in the expanded access or compassionate use program for PV-10 are also receiving PV-10 treatments for cutaneous and subcutaneous cancer indications. The Company also focuses on over-the-counter (OTC) products and various other non-core technologies. PV-10 is a sterile injectable form of rose bengal disodium (Rose Bengal), for direct injection into tumors.

Webull offers Provectus Biopharmaceuticals Inc stock information, including OTCMQB: PVCT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PVCT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PVCT stock methods without spending real money on the virtual paper trading platform.